Press Release – Expansion Therapeutics

Press Release

Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President

Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today…

Expansion TherapeuticsOctober 5, 2020

Press Release

Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board

Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases…

Expansion TherapeuticsJune 17, 2019

Press Release

Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer

Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…

Expansion TherapeuticsNovember 13, 2018

Press Release

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

Names Kevin M. Forrest, Ph.D. President and CEO Proprietary technology based on pioneering work from…

Expansion TherapeuticsJanuary 3, 2018